• Safety & Recalls
  • Regulatory Updates
  • Drug Coverage
  • COPD
  • Cardiovascular
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Clinical Pharmacology
  • Pediatrics
  • Urology
  • Pharmacy
  • Idiopathic Pulmonary Fibrosis
  • Diabetes and Endocrinology
  • Allergy, Immunology, and ENT
  • Musculoskeletal/Rheumatology
  • Respiratory
  • Psychiatry and Behavioral Health
  • Dermatology
  • Oncology

First-time generic approvals (November 2006)

Article

Levonorgestrel and ethinyl estradiol tablets, 0.15/0.03 mg (equiv to Seasonale tablets)

Levonorgestrel and ethinyl estradiol tablets, 0.15/0.03 mg (equiv to Seasonale tablets)

WATSON

Topiramate tablets, 25, 100, and 200 mg (equiv to Topamax tablets)

Diltiazem extended-release capsules, 120, 180, 240, 300, 360, and 420 mg (equiv to Tiazac extended-release capsules)

KV PHARMACEUTICAL

Prednicarbate cream, 0.1% (emollient) (equiv to Dermatop emollient cream, 0.1%)

ALTANA

Caffeine citrate injection, 20 mg/mL, packaged in 60 mg/3 mL single-dose vials (equiv to Cafcit injection)

PHARMAFORCE

Caffeine citrate oral solution, 20 mg/mL, packaged in 60 mg/3 mL vials (equiv to Cafcit oral solution)

PHARMAFORCE

Balanced salt solution (sterile irrigation solution) (equiv to BSS sterile irrigating solution)

AKORN

© 2024 MJH Life Sciences

All rights reserved.